title: Hitting the Target in BRAF-Mutant Colorectal Cancer.
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
authors.forename: Ankur K
authors.initials: AK
authors.lastname: Nagaraja
authors.affiliation: Dana-Farber Cancer Institute, Harvard Medical School, Boston; and Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA adam_bass@dfci.harvard.edu.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Bass
mesh_terms: D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D048369:MAP Kinase Kinase 1 / Q000037:antagonists & inhibitors*; D008297:Male; D009154:Mutation / Q000235:genetics*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors* / Q000235:genetics*; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D007211:Indoles; D013449:Sulfonamides; D048493:Proto-Oncogene Proteins B-raf; D048369:MAP Kinase Kinase 1